Penicillin APIs (Amoxicillin, etc.)
Bacterial Infections
ApprovedCommercial
Key Facts
About Nectar Lifesciences
Nectar Lifesciences is a vertically integrated pharmaceutical company with a core focus on anti-infectives, especially cephalosporins and penicillins. The company has established itself as a major global API manufacturer and exporter, with a significant portfolio of over 100 products and a robust R&D pipeline. Its strategic direction involves expanding its presence in regulated markets, diversifying into new therapeutic areas like oncology and cardiology, and leveraging its manufacturing excellence for contract manufacturing opportunities.
View full company profileOther Bacterial Infections Drugs
| Drug | Company | Phase |
|---|---|---|
| Novel Antibiotics | Shionogi | Various |
| Anti-infectives Portfolio | Aurobindo Pharma | Commercial |
| Azithromycin products | Alkem Laboratories | Commercial |
| Cefixime & Ofloxacin combinations | Ipca Laboratories | Commercial |
| Antibiotic Portfolio | SPIMACO | Approved/Commercial |
| Zevtera® (ceftobiprole medocaril) | Basilea Pharmaceutica | Approved/Commercial |
| Cephalosporin APIs (Cefixime, Cefpodoxime, etc.) | Nectar Lifesciences | Approved |
| Vibativ® (telavancin) | Cleo Life Sciences | Approved |